fluoxetine has been researched along with leucine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Schaechter, JD; Wurtman, RJ | 1 |
Suh, HH; Tseng, LL | 1 |
Idoate, I; Larralde, J; Urdaneta, E | 1 |
Dutertre, S; Lewis, RJ; Paczkowski, FA; Sharpe, IA | 1 |
Lewis, RJ; Ramu, S; Shaikh, NH; Wang, CI | 1 |
7 other study(ies) available for fluoxetine and leucine
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Serotonin release varies with brain tryptophan levels.
Topics: Animals; Biological Availability; Electric Stimulation; Fluoxetine; Hydroxyindoleacetic Acid; Hypothalamus; In Vitro Techniques; Leucine; Male; Membrane Potentials; Rats; Rats, Inbred Strains; Serotonin; Tryptophan | 1990 |
Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
Topics: Analgesics; Animals; beta-Endorphin; Desipramine; Fluoxetine; Injections, Intraventricular; Injections, Spinal; Leucine; Male; Mice; Mice, Inbred ICR; Morphine; Reaction Time; Thiorphan | 1990 |
Drug-nutrient interactions: inhibition of amino acid intestinal absorption by fluoxetine.
Topics: Animals; Culture Techniques; Enzyme Inhibitors; Fluoxetine; Food-Drug Interactions; Intestinal Absorption; Intestinal Mucosa; Jejunum; Leucine; Male; Microvilli; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sodium-Potassium-Exchanging ATPase; Time Factors | 1998 |
chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.
Topics: Adrenergic alpha-Agonists; Amino Acid Sequence; Animals; Antidepressive Agents, Tricyclic; Biological Transport; Conotoxins; Crystallography, X-Ray; Dopamine; Fluoxetine; Glutamic Acid; Humans; Leucine; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Neurotoxins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Protein Isoforms; Protein Structure, Tertiary; Sequence Alignment | 2007 |
A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.
Topics: Adrenergic Uptake Inhibitors; Animals; Binding Sites; Biological Transport; Chlorocebus aethiops; Computer Simulation; COS Cells; Fluoxetine; Humans; Leucine; Molecular Docking Simulation; Mutagenesis, Site-Directed; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins | 2012 |